Swiss pharmaceutical giant Roche will invest over $50 billion in the U.S. within the next five years, following President Trump’s proposed tariffs on imported drugs. The U.S. market is crucial for Roche, contributing over half of its pharmaceutical division’s revenue.
- Roche plans to expand manufacturing and distribution in Kentucky, Indiana, New Jersey, Oregon, and California.
- A gene therapy facility will be established in Pennsylvania.
- A 900,000 sq ft manufacturing center for weight loss medicines is planned.
- Indiana will house a new glucose monitoring facility.
- An R&D center in Massachusetts will focus on AI and cardiovascular research.
This investment will also increase Roche’s employee presence across eight U.S. states.
Tags #Business, #Science, #Technology
Want to read more about this ? One of the original source articles from a trusted news source (not legacy media) is here:
